APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biolayer Interferometry (BLI)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biolayer Interferometry (BLI) Industry Growth and Trends Forecast to 2032

2 May 2026101 pages

Choose your research edition.

Industry ResearchBiolayer Interferometry (BLI) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Biolayer Interferometry (BLI) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biolayer Interferometry (BLI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biolayer Interferometry (BLI) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Biolayer Interferometry (BLI) Market Analysis and Forecast 2026-2032229 pages · $4,950 USD

Market perspective

According to APO Research, the global Biolayer Interferometry (BLI) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biolayer Interferometry (BLI) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biolayer Interferometry (BLI) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biolayer Interferometry (BLI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biolayer Interferometry (BLI) market include Ichor Life Sciences, Inc, Creative BioMart, GenScript, ROCKLAND IMMUNOCHEMICALS, INC, BPS Bioscience, Inc, Creative Proteomics, Creative Biostructure, Profacgen and Creative Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biolayer Interferometry (BLI) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biolayer Interferometry (BLI) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biolayer Interferometry (BLI) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biolayer Interferometry (BLI).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biolayer Interferometry (BLI) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biolayer Interferometry (BLI) Market by Company

Ichor Life Sciences, Inc

Creative BioMart

GenScript

ROCKLAND IMMUNOCHEMICALS, INC

BPS Bioscience, Inc

Creative Proteomics

Creative Biostructure

Profacgen

Creative Biolabs

Biocult

KMD Bioscience Co., Ltd

Biolayer Interferometry (BLI) Segment by Type

Affinity and Kinetic Analysis

Drug and Antibody Screening

Drug and Antibody Discovery

Protein Quantification

Others

Biolayer Interferometry (BLI) Segment by Application

Pharmaceutical Industry

Diagnostics

Biotechnology

Scientific Research

Others

Biolayer Interferometry (BLI) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biolayer Interferometry (BLI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biolayer Interferometry (BLI) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biolayer Interferometry (BLI).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biolayer Interferometry (BLI) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biolayer Interferometry (BLI) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biolayer Interferometry (BLI) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biolayer Interferometry (BLI) Market Share by Region (2021-2026) Table 4. Global Biolayer Interferometry (BLI) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biolayer Interferometry (BLI) Market Share by Region (2027-2032) Table 6. Global Biolayer Interferometry (BLI) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biolayer Interferometry (BLI) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biolayer Interferometry (BLI) Market Size Share by Type (2021-2026) Table 9. Global Biolayer Interferometry (BLI) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biolayer Interferometry (BLI) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biolayer Interferometry (BLI) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biolayer Interferometry (BLI) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biolayer Interferometry (BLI) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biolayer Interferometry (BLI) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biolayer Interferometry (BLI) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biolayer Interferometry (BLI) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biolayer Interferometry (BLI) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biolayer Interferometry (BLI) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biolayer Interferometry (BLI) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biolayer Interferometry (BLI) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biolayer Interferometry (BLI) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biolayer Interferometry (BLI) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biolayer Interferometry (BLI) Market Size Share by Application (2021-2026) Table 24. Global Biolayer Interferometry (BLI) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biolayer Interferometry (BLI) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biolayer Interferometry (BLI) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biolayer Interferometry (BLI) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biolayer Interferometry (BLI) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biolayer Interferometry (BLI) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biolayer Interferometry (BLI) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biolayer Interferometry (BLI) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biolayer Interferometry (BLI) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biolayer Interferometry (BLI) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biolayer Interferometry (BLI) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biolayer Interferometry (BLI) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biolayer Interferometry (BLI) Industry Trends Table 37. Biolayer Interferometry (BLI) Industry Drivers Table 38. Biolayer Interferometry (BLI) Industry Opportunities and Challenges Table 39. Biolayer Interferometry (BLI) Industry Restraints Table 40. Global Biolayer Interferometry (BLI) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biolayer Interferometry (BLI) Revenue Market Share by Company (2021-2026) Table 42. Global Biolayer Interferometry (BLI) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biolayer Interferometry (BLI) Key Company Headquarters & Area Served Table 44. Global Biolayer Interferometry (BLI) Company, Product Type & Application Table 45. Global Biolayer Interferometry (BLI) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biolayer Interferometry (BLI) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Ichor Life Sciences, Inc Company Information Table 49. Ichor Life Sciences, Inc Business Overview Table 50. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product Portfolio Table 52. Ichor Life Sciences, Inc Recent Development Table 53. Creative BioMart Company Information Table 54. Creative BioMart Business Overview Table 55. Creative BioMart Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Creative BioMart Biolayer Interferometry (BLI) Product Portfolio Table 57. Creative BioMart Recent Development Table 58. GenScript Company Information Table 59. GenScript Business Overview Table 60. GenScript Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GenScript Biolayer Interferometry (BLI) Product Portfolio Table 62. GenScript Recent Development Table 63. ROCKLAND IMMUNOCHEMICALS, INC Company Information Table 64. ROCKLAND IMMUNOCHEMICALS, INC Business Overview Table 65. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product Portfolio Table 67. ROCKLAND IMMUNOCHEMICALS, INC Recent Development Table 68. BPS Bioscience, Inc Company Information Table 69. BPS Bioscience, Inc Business Overview Table 70. BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. BPS Bioscience, Inc Biolayer Interferometry (BLI) Product Portfolio Table 72. BPS Bioscience, Inc Recent Development Table 73. Creative Proteomics Company Information Table 74. Creative Proteomics Business Overview Table 75. Creative Proteomics Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Creative Proteomics Biolayer Interferometry (BLI) Product Portfolio Table 77. Creative Proteomics Recent Development Table 78. Creative Biostructure Company Information Table 79. Creative Biostructure Business Overview Table 80. Creative Biostructure Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Creative Biostructure Biolayer Interferometry (BLI) Product Portfolio Table 82. Creative Biostructure Recent Development Table 83. Profacgen Company Information Table 84. Profacgen Business Overview Table 85. Profacgen Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Profacgen Biolayer Interferometry (BLI) Product Portfolio Table 87. Profacgen Recent Development Table 88. Creative Biolabs Company Information Table 89. Creative Biolabs Business Overview Table 90. Creative Biolabs Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Creative Biolabs Biolayer Interferometry (BLI) Product Portfolio Table 92. Creative Biolabs Recent Development Table 93. Biocult Company Information Table 94. Biocult Business Overview Table 95. Biocult Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Biocult Biolayer Interferometry (BLI) Product Portfolio Table 97. Biocult Recent Development Table 98. KMD Bioscience Co., Ltd Company Information Table 99. KMD Bioscience Co., Ltd Business Overview Table 100. KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product Portfolio Table 102. KMD Bioscience Co., Ltd Recent Development Table 103. North America Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Biolayer Interferometry (BLI) Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Biolayer Interferometry (BLI) Market Share by Country (2021-2026) Table 106. North America Biolayer Interferometry (BLI) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Biolayer Interferometry (BLI) Market Share Forecast by Country (2027-2032) Table 108. Europe Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Biolayer Interferometry (BLI) Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Biolayer Interferometry (BLI) Market Share by Country (2021-2026) Table 111. Europe Biolayer Interferometry (BLI) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Biolayer Interferometry (BLI) Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Biolayer Interferometry (BLI) Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Biolayer Interferometry (BLI) Market Share by Country (2021-2026) Table 116. Asia-Pacific Biolayer Interferometry (BLI) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Biolayer Interferometry (BLI) Market Share Forecast by Country (2027-2032) Table 118. Latin America Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Biolayer Interferometry (BLI) Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Biolayer Interferometry (BLI) Market Share by Country (2021-2026) Table 121. Latin America Biolayer Interferometry (BLI) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Biolayer Interferometry (BLI) Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Biolayer Interferometry (BLI) Market Share by Country (2021-2026) Table 126. Middle East & Africa Biolayer Interferometry (BLI) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Biolayer Interferometry (BLI) Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biolayer Interferometry (BLI) Product Image Figure 3. Global Biolayer Interferometry (BLI) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 5. Global Biolayer Interferometry (BLI) Market Share by Region: 2025 VS 2032 Figure 6. Global Biolayer Interferometry (BLI) Market Share by Region (2021-2032) Figure 7. North America Biolayer Interferometry (BLI) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biolayer Interferometry (BLI) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biolayer Interferometry (BLI) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biolayer Interferometry (BLI) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biolayer Interferometry (BLI) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Affinity and Kinetic Analysis Image Figure 13. Global Affinity and Kinetic Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Drug and Antibody Screening Image Figure 15. Global Drug and Antibody Screening Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Drug and Antibody Discovery Image Figure 17. Global Drug and Antibody Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Protein Quantification Image Figure 19. Global Protein Quantification Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Biolayer Interferometry (BLI) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Biolayer Interferometry (BLI) Market Share by Type 2025 VS 2032 Figure 24. North America Biolayer Interferometry (BLI) Market Size Share by Type (2021-2032) Figure 25. Europe Biolayer Interferometry (BLI) Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Biolayer Interferometry (BLI) Market Size Share by Type (2021-2032) Figure 27. Latin America Biolayer Interferometry (BLI) Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Biolayer Interferometry (BLI) Market Size Share by Type (2021-2032) Figure 29. Pharmaceutical Industry Image Figure 30. Global Pharmaceutical Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Diagnostics Image Figure 32. Global Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Biotechnology Image Figure 34. Global Biotechnology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Scientific Research Image Figure 36. Global Scientific Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Biolayer Interferometry (BLI) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Biolayer Interferometry (BLI) Market Share by Application 2025 VS 2032 Figure 41. North America Biolayer Interferometry (BLI) Market Size Share by Application (2021-2032) Figure 42. Europe Biolayer Interferometry (BLI) Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Biolayer Interferometry (BLI) Market Size Share by Application (2021-2032) Figure 44. Latin America Biolayer Interferometry (BLI) Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Biolayer Interferometry (BLI) Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Biolayer Interferometry (BLI) Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Biolayer Interferometry (BLI) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Biolayer Interferometry (BLI) Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Biolayer Interferometry (BLI) Market Share by Country (2021-2032) Figure 51. Europe Biolayer Interferometry (BLI) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Biolayer Interferometry (BLI) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Biolayer Interferometry (BLI) Market Share by Country (2021-2032) Figure 54. Asia-Pacific Biolayer Interferometry (BLI) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Biolayer Interferometry (BLI) Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Biolayer Interferometry (BLI) Market Share by Country (2021-2032) Figure 57. Latin America Biolayer Interferometry (BLI) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Biolayer Interferometry (BLI) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Biolayer Interferometry (BLI) Market Share by Country (2021-2032) Figure 60. Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Biolayer Interferometry (BLI) Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Biolayer Interferometry (BLI) Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Affinity and Kinetic Analysis
  • Drug and Antibody Screening
  • Drug and Antibody Discovery
  • Protein Quantification
  • Others
Applications
  • Pharmaceutical Industry
  • Diagnostics
  • Biotechnology
  • Scientific Research
  • Others
Companies covered
  • Ichor Life Sciences, Inc
  • Creative BioMart
  • GenScript
  • ROCKLAND IMMUNOCHEMICALS, INC
  • BPS Bioscience, Inc
  • Creative Proteomics
  • Creative Biostructure
  • Profacgen
  • Creative Biolabs
  • Biocult
  • KMD Bioscience Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biolayer Interferometry (BLI) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biolayer Interferometry (BLI) Market Size by Region (2021-2032)
  5. 1.4.1 Global Biolayer Interferometry (BLI) Market Size by Region (2021-2026)
  6. 1.4.2 Global Biolayer Interferometry (BLI) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biolayer Interferometry (BLI) Market Size (2021-2032)
  8. 1.5.1 North America Biolayer Interferometry (BLI) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biolayer Interferometry (BLI) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biolayer Interferometry (BLI) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biolayer Interferometry (BLI) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biolayer Interferometry (BLI) Market Size Growth Rate (2021-2032)
2 Biolayer Interferometry (BLI) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Affinity and Kinetic Analysis
  3. 2.1.2 Drug and Antibody Screening
  4. 2.1.3 Drug and Antibody Discovery
  5. 2.1.4 Protein Quantification
  6. 2.1.5 Others
  7. 2.2 Global Biolayer Interferometry (BLI) Market Size by Type
  8. 2.2.1 Global Biolayer Interferometry (BLI) Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Biolayer Interferometry (BLI) Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Biolayer Interferometry (BLI) Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Biolayer Interferometry (BLI) Market Size by Regions
  12. 2.3.1 North America Biolayer Interferometry (BLI) Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Biolayer Interferometry (BLI) Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Biolayer Interferometry (BLI) Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Biolayer Interferometry (BLI) Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Biolayer Interferometry (BLI) Market Size Breakdown by Type (2021-2026)
3 Biolayer Interferometry (BLI) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Industry
  3. 3.1.2 Diagnostics
  4. 3.1.3 Biotechnology
  5. 3.1.4 Scientific Research
  6. 3.1.5 Others
  7. 3.2 Global Biolayer Interferometry (BLI) Market Size by Application
  8. 3.2.1 Global Biolayer Interferometry (BLI) Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Biolayer Interferometry (BLI) Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Biolayer Interferometry (BLI) Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Biolayer Interferometry (BLI) Market Size by Regions
  12. 3.3.1 North America Biolayer Interferometry (BLI) Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Biolayer Interferometry (BLI) Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Biolayer Interferometry (BLI) Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Biolayer Interferometry (BLI) Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Biolayer Interferometry (BLI) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biolayer Interferometry (BLI) Industry Trends
  2. 4.2 Biolayer Interferometry (BLI) Industry Drivers
  3. 4.3 Biolayer Interferometry (BLI) Industry Opportunities and Challenges
  4. 4.4 Biolayer Interferometry (BLI) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biolayer Interferometry (BLI) Revenue (2021-2026)
  2. 5.2 Global Biolayer Interferometry (BLI) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biolayer Interferometry (BLI) Key Company Headquarters & Area Served
  4. 5.4 Global Biolayer Interferometry (BLI) Company, Product Type & Application
  5. 5.5 Global Biolayer Interferometry (BLI) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biolayer Interferometry (BLI) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biolayer Interferometry (BLI) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biolayer Interferometry (BLI) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Ichor Life Sciences, Inc
  2. 6.1.1 Ichor Life Sciences, Inc Company Information
  3. 6.1.2 Ichor Life Sciences, Inc Business Overview
  4. 6.1.3 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product Portfolio
  6. 6.1.5 Ichor Life Sciences, Inc Recent Developments
  7. 6.2 Creative BioMart
  8. 6.2.1 Creative BioMart Company Information
  9. 6.2.2 Creative BioMart Business Overview
  10. 6.2.3 Creative BioMart Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Creative BioMart Biolayer Interferometry (BLI) Product Portfolio
  12. 6.2.5 Creative BioMart Recent Developments
  13. 6.3 GenScript
  14. 6.3.1 GenScript Company Information
  15. 6.3.2 GenScript Business Overview
  16. 6.3.3 GenScript Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GenScript Biolayer Interferometry (BLI) Product Portfolio
  18. 6.3.5 GenScript Recent Developments
  19. 6.4 ROCKLAND IMMUNOCHEMICALS, INC
  20. 6.4.1 ROCKLAND IMMUNOCHEMICALS, INC Company Information
  21. 6.4.2 ROCKLAND IMMUNOCHEMICALS, INC Business Overview
  22. 6.4.3 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product Portfolio
  24. 6.4.5 ROCKLAND IMMUNOCHEMICALS, INC Recent Developments
  25. 6.5 BPS Bioscience, Inc
  26. 6.5.1 BPS Bioscience, Inc Company Information
  27. 6.5.2 BPS Bioscience, Inc Business Overview
  28. 6.5.3 BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 BPS Bioscience, Inc Biolayer Interferometry (BLI) Product Portfolio
  30. 6.5.5 BPS Bioscience, Inc Recent Developments
  31. 6.6 Creative Proteomics
  32. 6.6.1 Creative Proteomics Company Information
  33. 6.6.2 Creative Proteomics Business Overview
  34. 6.6.3 Creative Proteomics Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Creative Proteomics Biolayer Interferometry (BLI) Product Portfolio
  36. 6.6.5 Creative Proteomics Recent Developments
  37. 6.7 Creative Biostructure
  38. 6.7.1 Creative Biostructure Company Information
  39. 6.7.2 Creative Biostructure Business Overview
  40. 6.7.3 Creative Biostructure Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Creative Biostructure Biolayer Interferometry (BLI) Product Portfolio
  42. 6.7.5 Creative Biostructure Recent Developments
  43. 6.8 Profacgen
  44. 6.8.1 Profacgen Company Information
  45. 6.8.2 Profacgen Business Overview
  46. 6.8.3 Profacgen Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Profacgen Biolayer Interferometry (BLI) Product Portfolio
  48. 6.8.5 Profacgen Recent Developments
  49. 6.9 Creative Biolabs
  50. 6.9.1 Creative Biolabs Company Information
  51. 6.9.2 Creative Biolabs Business Overview
  52. 6.9.3 Creative Biolabs Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Creative Biolabs Biolayer Interferometry (BLI) Product Portfolio
  54. 6.9.5 Creative Biolabs Recent Developments
  55. 6.10 Biocult
  56. 6.10.1 Biocult Company Information
  57. 6.10.2 Biocult Business Overview
  58. 6.10.3 Biocult Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Biocult Biolayer Interferometry (BLI) Product Portfolio
  60. 6.10.5 Biocult Recent Developments
  61. 6.11 KMD Bioscience Co., Ltd
  62. 6.11.1 KMD Bioscience Co., Ltd Company Information
  63. 6.11.2 KMD Bioscience Co., Ltd Business Overview
  64. 6.11.3 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product Portfolio
  66. 6.11.5 KMD Bioscience Co., Ltd Recent Developments
7 North America
  1. 7.1 North America Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
  3. 7.3 North America Biolayer Interferometry (BLI) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
  3. 8.3 Europe Biolayer Interferometry (BLI) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biolayer Interferometry (BLI) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
  3. 10.3 South America Biolayer Interferometry (BLI) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biolayer Interferometry (BLI) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst